Late-breaking abstracts may be submitted for poster or oral presentation; however, only a limited number of late-breaking abstracts will be selected for oral presentation.
To be eligible for late-breaking submission, the abstract:
- Cannot previously have been presented at a major scientific meeting (>1000 participants).
- Cannot be simply a revision of an abstract submitted for the regular deadline.
To be considered for oral rather than poster presentation, a late-breaking abstract must additionally:
- Describe recently acquired high-impact unpublished translational or basic research.
- Describe findings from large prospective phase 2/3 clinical trials. (Phase 1 or retrospective clinical trials abstracts will be eligible for poster presentation.)
Late-breaking abstracts will be accepted from Monday, January 9, 2016 until Friday, March 31, 2017.
Abstract submission will only be accepted online.
Industry professionals are permitted to present abstracts but the first and presenting author must declare if the study detailed in the abstract was funded by a pharmaceutical or biotech company or by a Foundation or academic group. Additionally, all authors must identify any financial interest in products or processes involved in their research. This includes stock ownership, membership on an advisory board or board of directors, corporate-sponsored research, or other substantive relationships such as employment.
TRIALS IN PROGRESS
Trial in Progress abstracts in all phases of clinical research (phases I to III) may be submitted for consideration.
It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis and consequently will only require the completion of two (2) sections: Background and Trial design.
Please note the following:
- Recruitment must have already begun or have been completed by the abstract submission deadline of
March 31, 2017.
- Abstracts including results or preliminary data will be rejected.
- Abstracts will be reviewed by the BioIron 2017 Scientific Committee and considered on the merits of the scientific and clinical rationale of the trial.
- Trial in Progress abstracts will not be considered for Podium (Oral) presentation
Important information for abstract submission: (List of Topics)
- Membership in the Society is not a requirement for submitting an abstract.
- You will receive a reply email after you submit your abstract, which will verify that your abstract was received by the BioIron meeting office. The email will also provide an abstract number to use as a reference number.
- Avoid excessive abbreviations in abstract. Abbreviations may only be used after the words are written out in full at first mention, for example, iron sulfur cluster (ISC).
- The abstract should be informative and detailed. It should include the following information: a) an introduction, b) methods, c) results obtained, d) discussion, and e) conclusions. The detail of the abstract does not necessarily have to contain headings for these objectives, methods, results, discussion, and conclusions; however, the abstract must contain this information. It is not acceptable to merely state that "the results will be discussed."
- It is the author's responsibility to submit the abstract in perfect order with no errors in spelling or grammar. Abstracts will not be retyped or corrected.
- Presenters of accepted abstracts are expected to register for and attend the BioIron 2017 meeting.
Please check that your abstract is prepared with the following formatting before submitting:
- All abstract submissions will be entered (or copy/pasted) directly into a text field on the submission form; however, to ensure that your abstract complies with the formatting standards required for your submission to be accepted, please first create your abstract in a word document or rich text file with the following format settings.
- There is a maximum word limit of 550 words, which includes the title, authors and body of your abstract.
- The following formatting mustapply to your document's page settings:
- The abstract text (including the title of the abstract and the authors' first names, last names, and first authors' affiliation) and graphics must fit on one (1) page.
- All margins must be set at 1.25 inches
- Font Face must be Arial
- Font size must be 10 pt
- Line spacing must be single
- A single figure or illustration may be used in your abstract; (see example figure/illustration)
The abstract title should be listed first, typed in BOLD, CAPITAL LETTERS. The authors' initials and surnames followed by the first authors' affiliation should follow the title. The presenter's initials and surname should be listed first. Following is an example of how your abstract should appear:
- If using a figure/illustration, your completed abstract and figure/illustration must still fit onto a single page.
- The maximum dimensions of your figure/illustration image is a width of 580 pixels and a height of 250 pixels.
- Images that are found to have larger dimensions than allowed will automatically be resized to comply with those specifications. Auto resizing may causeloss of image quality; therefore you should make sure to keep your image dimensions less than or equal to the allowed width and height.
- Allowed image formats to upload are as follows: jpeg, jpg, gif, bmp; however, images will be converted to jpg (jpeg) during the submission process for consistency and embedding into the abstract document.
- The example used above, is a table generated in a word document, then using a screen shot of the data, a photo editor was used to crop the surrounding whitespace to make the image as compact as possible and sized according to the allowed measurements and in the allowed file format. There are many good free photo editors on the internet should one be needed.
TITLE TYPED FIRST IN BOLD, CAPITAL LETTERS
M. Smith, J. Doe, R. Stevens, University of Chicago
Following the first authors’ affiliation, type abstract text here
(optionally) Followed by a single figure or illustration (formatted as listed above).
How to submit/add an abstract
- Once signed in, create a presenting author.
- Once a presenting author is created, there will be a link for submission options for that presenter.
- From the submission options page, you will find a link to add a new submission.
- Click the link to add a new submission and enter your abstract information, including topic selection and presentation preference.
How to view/edit/delete an abstract
- If you have already made one or more abstract submissions for a particular presenter, click the submission options link to navigate to the submissions for that presenter.
- For each submission, you can view the output, edit or delete that submission.
If you require assistance, please email firstname.lastname@example.org and describe the problem you are experiencing.